19 May 2013
Keywords: chmp, issues, positive, opinion, palonosetron, swiss, privately-owned
Article | 10 January 2005
Swiss privately-owned pharmaceutical group Helsinn Healthcare says that, following the European Union's Centralized Procedure and on the basis of quality, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.